4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-23-005906
General Counsel sold 848 shares at $11.78 ($9,989)
- General Counsel acquired 1,924 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ring Christine General Counsel | 2023-01-30 | Option exercise | +1,924 | 8,109 | D: show line 1 in the form | ||
| Ring Christine General Counsel | 2023-01-30 | Sale | −848 | $11.78 | $9,989 | 7,261 | D: show line 2 in the form |
| Open-market sales · 848 sh · avg $11.78 · $9,989 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ring Christine General Counsel | 2023-01-30 | Option exercise · Restricted Stock Units | −1,924 | 23,089 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…